Biopharma · FDA Approvals · Stock
TRAW Traws Pharma
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that thr…
Catalyst calendar
Dated catalysts for TRAW, including recently decided ones.
Nothing scheduled in this window.
Recent first-hand events
Every first-hand event for TRAW, newest first.
Instant stream — events appear as soon as they are filed.
Decision-gradeMaterialNotableMinor
No events yet.
Peers by market cap
Companies in the same sector closest to TRAW in market value.
ACXPAcurx PharmaceuticalsMarket cap $4.5M · 1 tracked drug · 1 upcoming catalyst
ICCMIceCure MedicalMarket cap $4.4M · 1 tracked drug
AZTRAzitraMarket cap $4.7M · 2 tracked drugs · 2 upcoming catalysts
IMNNImunonMarket cap $5.1M · 1 tracked drug
PULMPulmatrixMarket cap $5.1M
SNTISenti BiosciencesMarket cap $5.1M · 1 tracked drug
AEMDAethlon MedicalMarket cap $3.9M · 1 tracked drug
DRMADermata TherapeuticsMarket cap $3.8M · 1 tracked drug